Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | TECH | HALO | ||
| Company | Verona Pharma Plc ADR | Bio-Techne Corp | Halozyme Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 106.85 | 59.14 | 68.31 | ||
| High | 106.93 | 59.34 | 68.95 | ||
| Low | 106.81 | 58.76 | 67.95 | ||
| Latest | 106.91 | 59.22 | 68.87 | ||
| Change | +0.12 | +0.03 | +0.46 | ||
| % Change | +0.11% | +0.05% | +0.67% | ||
| Volume | 1,871,900 | 559,141 | 604,900 | ||
| 20-Day Average Volume | 1,504,320 | 1,678,607 | 2,257,195 | ||
| Previous Close | 106.79 | 59.19 | 68.41 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 106.48 | 60.20 | 65.42 | ||
| 20-Day Raw Stochastic | 98.26% | 30.37% | 66.19% | ||
| 20-Day Relative Strength | 70.52 | 48.18 | 55.19 | ||
| Weighted Alpha | +201.62 | -13.22 | +38.26 | ||
| Today's Opinion | 100% Buy | 40% Buy | 32% Buy | ||
| Previous Opinion | 100% Buy | 40% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 09/29/25 | +3.71% since 12/18/25 | +5.77% since 12/18/25 | ||
| Low | 106.61 on 09/30/25 | 57.03 on 12/19/25 | 65.11 on 12/19/25 | ||
| High | 106.93 on 10/06/25 | 59.58 on 12/23/25 | 69.28 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | +0.56% since 09/05/25 | -8.37% since 11/26/25 | -5.22% since 11/26/25 | ||
| Low | 105.78 on 09/19/25 | 56.59 on 12/16/25 | 61.22 on 12/11/25 | ||
| High | 106.93 on 10/06/25 | 65.25 on 12/01/25 | 72.78 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | +16.80% since 07/03/25 | +14.21% since 09/26/25 | -6.62% since 09/26/25 | ||
| Low | 86.63 on 07/08/25 | 51.32 on 09/29/25 | 61.22 on 12/11/25 | ||
| High | 106.93 on 10/06/25 | 66.96 on 10/24/25 | 76.30 on 10/01/25 | ||
| 6-Month | |||||
| %Chg | +98.35% since 04/04/25 | +12.16% since 06/26/25 | +31.11% since 06/26/25 | ||
| Low | 47.20 on 04/07/25 | 47.65 on 08/06/25 | 51.06 on 06/30/25 | ||
| High | 106.93 on 10/06/25 | 66.96 on 10/24/25 | 79.50 on 09/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,748,446 | 9,222,571 | 8,044,811 | ||
| Shares Outstanding, K | 81,830 | 155,813 | 117,597 | ||
| Annual Sales | 42,280,000 | 1,219,640,000 | 1,015,320,000 | ||
| Annual Net Income | -173,420,000 | 73,400,000 | 444,090,000 | ||
| Last Quarter Sales | 103,140,000 | 286,560,000 | 354,260,000 | ||
| Last Quarter Net Income | 11,920,000 | 38,190,000 | 175,230,000 | ||
| 60-Month Beta | 0.05 | 1.46 | 0.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 08/06/25 | 0.42 on 11/05/25 | 1.72 on 11/03/25 | ||
| Latest Earnings Date | 11/03/25 | 02/04/26 | 02/17/26 | ||
| Most Recent Dividend | N/A | 0.080 on 11/17/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 11/17/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 34.45 | 12.85 | ||